Drug design based on the substrate specificity of the efflux transporters expressed in the blood-brain barrier
Drug design based on the substrate specificity of the efflux transporters expressed in the blood-brain barrier
批准号:
13470495
负责人:
SUGIYAMA Yuichi
金额:
$7.04万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1. The contribution of efflux transporter expressed in the blood-brain barrier was investigated in this study to identify the transporter which plays a major role in the detoxification system in the central nervous system. According to the comparison of efflux transport rate of estradiol 17β glucuronide after microinjection to the cerebral cortex in Mrp1 knockout mice and its wild-type suggested that Mrp1 plays a major role in the efflux transport of estradiol 17β glucuronide across the blood-brain barrier. In addition, it was turned out that multispecific organic anion transporters such as Oat3 and Oatp3 were expressed in the brain capillary where they localized on the abluminal membrane. In the blood CSF barreir, Oat3 and Oatp3 have been identified on the brush border membrane of the choroid epithelial cells, and they are responsible for the uptake of hydrophilic and amphipathic organic anions, respectively. Characterization of the uptake of cefaclor, a beta-lactam antibiotic reveale … More d the presence of additional uptake mechanism in the choroid plexus. These organic anion transporters provide barrier function to the brain capillary and choroid plexus, and keep the brain concentration of xenobiotics including drugs relatively low compared to their blood concentration. Especially for drugs, these transporters prevent CNS drugs reaching clinically significant concentrations in the brain by extruding drugs into the blood circulation. In addition to the drug transporters, we succeeded in characterization of Oatp14 as candidate transporter for thyroxine (T4). It is hypothesized that it plays an important role in supplying blood T4 into the central nervous system.2. The binding conformations of ligands of rat Oat3 by the automated conformational analysis program using molecular dynamics (CAMDAS) and the molecular superposing program based on the physical properties of functional groups in a molecular (SUPERPOSE) in order to search for the factors of substrate specificity of rat Oat3 in relation to three-dimensional structures of ligands. Finally, one binding conformation of ligands for Oat3 was obtained. Although Oat3 has broad substrate specificity, the substrate recognition by Oat3 can be described by one model. Less
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kusuhara H, et al.: "Expression and functional involvement of organic anion transporting polypeptide subtype 3 (Slc21a7) in rat choroid plexus"Pharm Res. (in press).
Kusuhara H 等:“大鼠脉络丛中有机阴离子转运多肽亚型 3 (Slc21a7) 的表达和功能参与”Pharm Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wang DS et al.: "Involvement of Organic Cation Transporter 1 in the Lactic Acidosis Caused by Metformin"Mol Pharmacol. (in press).
Wang DS 等人:“有机阳离子转运蛋白 1 参与二甲双胍引起的乳酸酸中毒”Mol Pharmacol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y.Nagata, et al.: "Expression and functional characterization of rat organic anion transporter3(rOat3)in the choroic plexus"Mol.Pharmacol.. (in press). (2002)
Y.Nagata 等人:“大鼠有机阴离子转运蛋白 3 (rOat3) 在脉络丛中的表达和功能特征”Mol.Pharmacol..(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wang DS et al.: "Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin"J. Pharmacol. Exp. Ther.. 302. 510-515 (2002)
Wang DS等:“有机阳离子转运蛋白1参与二甲双胍的肝脏和肠道分布”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
D.-S.Wang, et al.: "Involvement of Organic Cation Transporter 1 in the Lactic Acidosis Caused by Metformin"Mol Pharmacol. 63. 844-888 (2003)
D.-S.Wang 等人:“有机阳离子转运蛋白 1 参与二甲双胍引起的乳酸酸中毒”Mol Pharmacol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 20 条
Development of probe drugs for the evaluation of the functions of drug transporters in vivo in humans
-
批准号:20249008
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$29.7万
-
财政年份:2008
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Development of the quantitative prediction method of pharmacokinetics with considering the function of metabolic enzymes and transporters
-
批准号:17209005
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.78万
-
财政年份:2005
-
负责人:SUGIYAMA Yuichi
-
依托单位:
New strategy for the drug development of CNS acting drugs by regulating drug transport across the blood-brain barrier
-
批准号:15390035
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.94万
-
财政年份:2003
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Development of the system for prediction of drug-drug interactions in hepatobiliary transport process
-
批准号:13557219
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.45万
-
财政年份:2001
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Analysis of the vectorial transport of amino acid and drugs in epithelial cells.
-
批准号:12144201
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$32.77万
-
财政年份:2000
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Analysis of the factors governing the elimination route of therapeutic agents
-
批准号:11470509
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$9.22万
-
财政年份:1999
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Role of hepatic transporters in the detoxification
-
批准号:10044243
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$4.48万
-
财政年份:1998
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Development of recombinant proteins with an aim to increase their therapeutic activity by the regulation of intracellular sorting
-
批准号:10557230
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.06万
-
财政年份:1998
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Role of hepatic transporters in the detoxification
-
批准号:09044267
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$4.8万
-
财政年份:1997
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Analysis of multiplicity and polymorphism of drug transporters expressed in the liver.
-
批准号:09470501
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.51万
-
财政年份:1997
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Development of a method to predict in vivo drug metabolism and excretion from in vitro data with human hepatic tissues and/or recombinant proteins
-
批准号:08557125
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$9.28万
-
财政年份:1996
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Prediction of hepatobiliary transport of drugs : Contribution of carrier-mediated transport in the detoxication of xenobiotics
-
批准号:06402058
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$10.5万
-
财政年份:1994
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Development of drug delivery systems for cytokines with an aim of efficient exertion of their pharmacological effect
-
批准号:06557132
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$6.21万
-
财政年份:1994
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Analysis of drug disposition in the central nervous system based on the transport characteristics across the blood-brain barrier and blood-cerebrospinal fluid barrier : Special focus on Peptide
-
批准号:04452303
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.14万
-
财政年份:1992
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Development of the drug delivery system for brain and cancer using the inhibitory effect of some drugs on the active efflux : Application of physiological pharmacokinetics.
-
批准号:04557106
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$8.32万
-
财政年份:1992
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Kinetic analysis of receptor-mediated endocytosis of polypeptide hormones
-
批准号:02452267
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.71万
-
财政年份:1990
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Development of a drug delivery system using the receptors located on the cerebral microvessels : An approach based on the physiological pharmacokinetio model.
-
批准号:02557088
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$7.68万
-
财政年份:1990
-
负责人:SUGIYAMA Yuichi
-
依托单位:
Pharmacokinetic analysis of disposition of biologically active peptide in the body.
-
批准号:62570961
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.96万
-
财政年份:1987
-
负责人:SUGIYAMA Yuichi
-
依托单位:
海外基金